NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.380
-0.010 (-0.42%)
Apr 29, 2026, 11:42 AM EDT - Market open
NovaBridge Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 275 | 459 | 69 | 158 | 347 | 3,647 | |
| Market Cap Growth | 404.66% | 562.90% | -56.10% | -54.60% | -90.48% | 9.73% | |
| Enterprise Value | 69 | 234 | -134 | -238 | -223 | 2,916 | |
| Last Close Price | 2.39 | 3.98 | 0.85 | 1.90 | 4.18 | 47.39 | |
| PS Ratio | - | - | - | 249.50 | -223.95 | 263.21 | |
| PB Ratio | 1.19 | 1.99 | 0.34 | 0.65 | 0.82 | 5.08 | |
| P/TBV Ratio | 1.20 | 1.99 | 0.34 | 0.65 | 0.91 | 5.42 | |
| EV/Sales Ratio | - | - | - | - | - | 210.43 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Net Debt / Equity Ratio | -0.90 | -0.90 | -0.84 | -1.27 | -1.16 | -0.91 | |
| Net Debt / EBITDA Ratio | 2.21 | 2.21 | 3.31 | 6.35 | 9.27 | 2.02 | |
| Net Debt / FCF Ratio | 10.08 | 10.08 | 1.59 | 2.10 | 5.31 | 4.15 | |
| Asset Turnover | - | - | - | 0.00 | - | 0.02 | |
| Quick Ratio | 7.91 | 7.91 | 20.65 | 5.39 | 4.60 | 7.48 | |
| Current Ratio | 8.09 | 8.09 | 20.90 | 5.67 | 4.78 | 7.66 | |
| Return on Equity (ROE) | -40.89% | -40.89% | -22.40% | -24.75% | -26.08% | -45.78% | |
| Return on Assets (ROA) | -24.90% | -24.90% | -11.05% | -6.38% | -4.73% | -21.69% | |
| Return on Invested Capital (ROIC) | -330.29% | -343.99% | - | - | - | -338.80% | |
| Return on Capital Employed (ROCE) | -40.40% | -40.40% | -25.20% | -15.80% | -11.00% | -41.60% | |
| Earnings Yield | -31.96% | -19.25% | -32.12% | -131.74% | -106.82% | -10.06% | |
| FCF Yield | -7.45% | -4.49% | -154.11% | -93.01% | -26.58% | -4.33% | |
| Buyback Yield / Dilution | -17.96% | -17.96% | 2.45% | -0.86% | -8.63% | -11.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.